Michele Scott, MD
Family Medicine · Florence, SCNPI 1003888769
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 171 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$500
- AbbVie$417
- GSK$282
- Lilly USA, LLC$278
- Novartis$131
- Amgen$94
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $500 |
| AbbVie | 24 | $417 |
| GSK | 17 | $282 |
| Lilly USA, LLC | 20 | $278 |
| Novartis | 8 | $131 |
| Amgen | 7 | $94 |
| Merck | 6 | $88 |
| Pfizer | 6 | $80 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $74 |
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| AstraZeneca | 4 | $59 |
| Nestle Healthcare Nutrition Inc. | 3 | $52 |
| Boehringer Ingelheim | 3 | $47 |
| Dynavax Technologies Corporation | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Abbott | 2 | $34 |
| Bayer | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Ardelyx, Inc. | 1 | $30 |
| Johnson & Johnson | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $15 |
| Renalytix AI, Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $12 |
How this compares
$2,744 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $308 |
| Prednisone | 39 | $257 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $118 |
| Ondansetron OdtOndansetron | 11 | $99 |
| Fluconazole | 25 | $96 |
| Doxycycline Hyclate | 13 | $95 |
| Gabapentin | 12 | $80 |
| Ketoconazole | 11 | $79 |
| Azithromycin | 20 | $76 |
| Amoxicillin | 22 | $66 |
| Cephalexin | 11 | $61 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Florence
- Cory SmithFlorence$16K
- Donald BehlingFlorence$14K
- Clarence AlexanderFlorence$14K
- Ralph CroweFlorence$13K
- Guy McClaryFlorence$13K
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.